Jinling Hospital, China
Clinical trials sponsored by Jinling Hospital, China, explained in plain language.
-
Kidney cancer drug combo shows promise but trial stopped early
Disease control TerminatedThis study tested two drugs (toripalimab and lenvatinib) given before and after kidney cancer surgery in 17 people with different stages of kidney cancer. The goal was to see if the drugs could shrink or eliminate the tumor before surgery. The trial was stopped early, so results …
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 26, 2026 07:27 UTC
-
Can two diabetes drugs shield kidneys after cancer surgery?
Disease control TerminatedThis study looked at whether two drugs, finerenone and empagliflozin (used alone or together), could slow kidney function decline in people at high risk for chronic kidney disease after having a kidney removed for cancer. Ten participants took the drugs or no drug for one year, w…
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 22, 2026 14:04 UTC